236 related articles for article (PubMed ID: 17704093)
1. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
Lyne JC; Petryka J; Pennell DJ
Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
[No Abstract] [Full Text] [Related]
2. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
Damy T; Plante-Bordeneuve V; Valleix S
Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
[No Abstract] [Full Text] [Related]
4. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement.
Thomson LE
J Am Coll Cardiol; 2008 Mar; 51(10):1031-2. PubMed ID: 18325443
[No Abstract] [Full Text] [Related]
5. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.
Lehrke S; Steen H; Kristen AV; Merten C; Lossnitzer D; Dengler TJ; Katus HA; Giannitsis E
Amyloid; 2009 Dec; 16(4):187-95. PubMed ID: 19922329
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging.
Osman F; Foundon A; Leyva P; Pitt M; Murray RG
Int J Cardiol; 2008 Mar; 125(1):e4-5. PubMed ID: 17337076
[TBL] [Abstract][Full Text] [Related]
7. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease.
Marcu CB; Nijveldt R; Beek AM; Van Rossum AC
Heart Lung Circ; 2007 Apr; 16(2):70-8. PubMed ID: 17317312
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.
Kwong RY; Heydari B; Abbasi S; Steel K; Al-Mallah M; Wu H; Falk RH
Am J Cardiol; 2015 Aug; 116(4):622-9. PubMed ID: 26076990
[TBL] [Abstract][Full Text] [Related]
10. Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis.
Bucciarelli-Ducci C; Locca D; Barbeau G; Prasad SK
Eur Heart J; 2007 May; 28(10):1186. PubMed ID: 17121755
[No Abstract] [Full Text] [Related]
11. Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
Leeson CP; Myerson SG; Walls GB; Neubauer S; Ormerod OJ
Eur Heart J; 2006 Jul; 27(14):1670. PubMed ID: 16449244
[No Abstract] [Full Text] [Related]
12. Cardiovascular magnetic resonance in cardiac amyloidosis.
Kwong RY; Falk RH
Circulation; 2005 Jan; 111(2):122-4. PubMed ID: 15657385
[No Abstract] [Full Text] [Related]
13. MR Imaging and Cardiac Amyloidosis Where to Go From Here?
Selvanayagam JB; Leong DP
JACC Cardiovasc Imaging; 2010 Feb; 3(2):165-7. PubMed ID: 20159643
[No Abstract] [Full Text] [Related]
14. Images in cardiovascular medicine. Late enhancement of a left ventricular cardiac fibroma assessed with gadolinium-enhanced cardiovascular magnetic resonance.
De Cobelli F; Esposito A; Mellone R; Papa M; Varisco T; Besana R; del Maschio A
Circulation; 2005 Sep; 112(13):e242-3. PubMed ID: 16186429
[No Abstract] [Full Text] [Related]
15. [Abnormal gadolinium kinetics in cardio MRI - always an indication of cardiac amyloidosis?].
Baeßler B; Reuter H; Huntgeburth M; Bunck AC
Rofo; 2015 Mar; 187(3):189-91. PubMed ID: 25184217
[No Abstract] [Full Text] [Related]
16. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
[TBL] [Abstract][Full Text] [Related]
17. Case report. Cardiac amyloidosis mimicking Fabry's disease in cardiac magnetic resonance imaging.
Kirschbaum SW; Baks T; Kofflard MJ; van Geuns RJ
Clin Radiol; 2008 Nov; 63(11):1274-6. PubMed ID: 18929045
[No Abstract] [Full Text] [Related]
18. [MR imaging in cardiac amyloidosis--morphology, function and late enhancement].
Hosch W; Libicher M; Ley S; Heye T; Schnabel P; Dengler TJ; Katus HA; Kauffmann GW; Kauczor HU; Kristen AV
Rofo; 2008 Jul; 180(7):639-45. PubMed ID: 18561066
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyopathy: magnetic resonance imaging evaluation.
Mueller GC; Attili A
Semin Roentgenol; 2008 Jul; 43(3):204-22. PubMed ID: 18486682
[No Abstract] [Full Text] [Related]
20. Sub-aortic mitral impact lesion depicted by delayed enhancement cardiac magnetic resonance imaging.
Sparrow P; Merchant N
Eur Heart J; 2008 Oct; 29(19):2449. PubMed ID: 18390867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
